By Dhirendra Tripathi
Investing.com -- Moderna (NASDAQ: MRNA ) stock fell 4% Tuesday as reports came in that two large buyers have declined options to purchase more of its Covid-19 vaccines, a sign of a waning pandemic bringing down demand.
The African Union and Covax, the World Health Organization-backed group, decided not to obtain more of the vaccine as developing nations struggle to turn supplies into inoculations, Bloomberg reported.
Less than two months ago, the company had forecast higher vaccine sales for the second half of the year, pinning its estimates on Covid-19 becoming a flu-like endemic illness that would lead people to take shots on a regular basis.
While the African Union agreed to purchase 50 million doses for delivery in the first quarter, the body of 55 member states opted not to acquire another 60 million doses in the second quarter, according to the wire agency.
Covax turned down two purchase options - one for 166 million doses in the third quarter and a second for 166 million doses in the fourth.
Moderna said it has signed deals for $21 billion in 2022 vaccine sales, up from $19 billion announced in February.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.